Alliance Pharma Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	178.84	180.68	167.42	163.21	129.8	Upgrade
Revenue Growth (YoY)	-1.02%	7.92%	2.58%	25.74%	-4.30%	Upgrade
Cost of Revenue	69.55	75.66	65.73	53.76	46.99	Upgrade
Gross Profit	109.29	105.02	101.68	109.45	82.82	Upgrade
Selling, General & Admin	70.41	52.47	63.96	60.2	44.61	Upgrade
Operating Expenses	80.43	62.46	73.25	70.98	53.14	Upgrade
Operating Income	28.85	42.56	28.43	38.47	29.67	Upgrade
Interest Expense	-8.95	-9.99	-5.43	-3.65	-2.66	Upgrade
Interest & Investment Income	0.06	0.11	0.02	0.02	0.01	Upgrade
Currency Exchange Gain (Loss)	0.78	-0.48	0.06	0.21	-0.65	Upgrade
Other Non Operating Income (Expenses)	-0.28	-	-	-	-	Upgrade
EBT Excluding Unusual Items	20.47	32.21	23.07	35.05	26.37	Upgrade
Merger & Restructuring Charges	-	-	-	-2.84	-1.3	Upgrade
Impairment of Goodwill	-1.69	-	-18.78	-	-1.14	Upgrade
Gain (Loss) on Sale of Assets	2.03	-	-	-	-	Upgrade
Asset Writedown	-34.83	-79.25	-27.71	-6.15	-10.91	Upgrade
Other Unusual Items	-0.44	-1.75	0.37	-7.9	-	Upgrade
Pretax Income	-14.46	-48.8	-23.05	18.16	13.02	Upgrade
Income Tax Expense	-3.73	-15.66	-1.84	10.84	4.99	Upgrade
Net Income	-10.73	-33.14	-21.21	7.32	8.03	Upgrade
Net Income to Common	-10.73	-33.14	-21.21	7.32	8.03	Upgrade
Net Income Growth	-	-	-	-8.82%	-67.91%	Upgrade
Shares Outstanding (Basic)	540	540	539	535	531	Upgrade
Shares Outstanding (Diluted)	540	540	539	542	537	Upgrade
Shares Change (YoY)	0.06%	0.12%	-0.53%	0.93%	1.35%	Upgrade
EPS (Basic)	-0.02	-0.06	-0.04	0.01	0.02	Upgrade
EPS (Diluted)	-0.02	-0.06	-0.04	0.01	0.01	Upgrade
EPS Growth	-	-	-	-9.40%	-68.43%	Upgrade
Free Cash Flow	37.88	30.71	20.61	37.13	36.96	Upgrade
Free Cash Flow Per Share	0.07	0.06	0.04	0.07	0.07	Upgrade
Dividend Per Share	-	-	0.018	0.017	0.016	Upgrade
Dividend Growth	-	-	5.03%	5.03%	200.37%	Upgrade
Gross Margin	61.11%	58.12%	60.74%	67.06%	63.80%	Upgrade
Operating Margin	16.13%	23.56%	16.98%	23.57%	22.86%	Upgrade
Profit Margin	-6.00%	-18.34%	-12.67%	4.48%	6.18%	Upgrade
Free Cash Flow Margin	21.18%	17.00%	12.31%	22.75%	28.47%	Upgrade
EBITDA	35.9	50.23	36.38	46.3	37.78	Upgrade
EBITDA Margin	20.08%	27.80%	21.73%	28.37%	29.11%	Upgrade
D&A For EBITDA	7.05	7.66	7.95	7.83	8.11	Upgrade
EBIT	28.85	42.56	28.43	38.47	29.67	Upgrade
EBIT Margin	16.13%	23.56%	16.98%	23.57%	22.86%	Upgrade
Effective Tax Rate	-	-	-	59.69%	38.33%	Upgrade

Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.